512600 Stock Overview
Manufactures and sells pharmaceutical intermediates and bulk drugs in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Astal Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹107.65 |
52 Week High | ₹131.70 |
52 Week Low | ₹32.05 |
Beta | -0.64 |
11 Month Change | -2.54% |
3 Month Change | 96.62% |
1 Year Change | 235.88% |
33 Year Change | 878.64% |
5 Year Change | n/a |
Change since IPO | 615.28% |
Recent News & Updates
Recent updates
Shareholder Returns
512600 | IN Diversified Financial | IN Market | |
---|---|---|---|
7D | -2.1% | 1.8% | 2.5% |
1Y | 235.9% | 52.5% | 46.3% |
Return vs Industry: 512600 exceeded the Indian Diversified Financial industry which returned 52.5% over the past year.
Return vs Market: 512600 exceeded the Indian Market which returned 46.3% over the past year.
Price Volatility
512600 volatility | |
---|---|
512600 Average Weekly Movement | 6.6% |
Diversified Financial Industry Average Movement | 6.6% |
Market Average Movement | 6.2% |
10% most volatile stocks in IN Market | 9.3% |
10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: 512600's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 512600's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | n/a | n/a | miel.co.in |
Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India.
Astal Laboratories Limited Fundamentals Summary
512600 fundamental statistics | |
---|---|
Market cap | ₹1.04b |
Earnings (TTM) | ₹24.61m |
Revenue (TTM) | ₹354.08m |
43.0x
P/E Ratio3.0x
P/S RatioIs 512600 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
512600 income statement (TTM) | |
---|---|
Revenue | ₹354.08m |
Cost of Revenue | ₹309.37m |
Gross Profit | ₹44.71m |
Other Expenses | ₹20.10m |
Earnings | ₹24.61m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.50 |
Gross Margin | 12.63% |
Net Profit Margin | 6.95% |
Debt/Equity Ratio | 1.3% |
How did 512600 perform over the long term?
See historical performance and comparison